Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer

Conditions: Differentiated Thyroid Carcinoma Interventions: Drug: ST-1898 tablets Sponsors: Beijing Scitech-Mq Pharmaceuticals Limited Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials